Evidence map›Paper›PMID 21166665›Full record

ArticleClinical and experimental immunology2011

The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.

M Bani-Ahmad, I S El-Amouri, C M Ko, F Lin, Y Tang-Feldman, O R Oakley

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

M Bani-AhmadDepartment of Clinical Sciences, University of Kentucky, Lexington, USA.
I S El-Amouri
C M Ko
F Lin
Y Tang-Feldman
O R Oakley
University of Kentucky · USCase Western Reserve University · USUniversity of California Davis Medical Center · US

Funding

Murine CMV Pneumonitis in Allogeneic BMTR15HL084654 · NHLBI · UNIVERSITY OF KENTUCKY · PI OAKLEY, OLIVER R · 2005 to 2005
$214k
NHLBI NIH HHS R15 HL084654NICHD NIH HHS 1R15HD065605-01
6 · The paper itself

Abstract

A wide variety of the host immune elements play an influential role in the defence against cytomegalovirus (CMV) infection. However, the role of complement in the clearance of CMV infection is less well studied. Decay accelerating factor (DAF/CD55) is a membrane-bound complement regulatory protein that inhibits the formation and accelerates the decay of C3-convertase. Here we hypothesize that murine CMV (MCMV) utilizes DAF as an immunoevasive strategy through down-regulation of host adaptive responses against the virus. To test our hypothesis, DAF knock-out (DAF KO) C57BL/6 mice and wild-type (WT) littermates were infected with a sublethal dose of MCMV, and their immune responses were compared. WT mice lost 7·8% of their initial weight within the first 4 days after infection and quickly began to recover. This is in contrast to the DAF KO mice, that lost a total of 19·4% of their initial weight and did not start recovery until 6 days post-infection. Flow cytometric analysis of lung digests revealed that infected DAF KO mice had a significantly increased infiltration of inflammatory cells, the majority being CD8(+) T lymphocytes. Serum levels of tumour necrosis factor (TNF)-α and interferon (IFN)-γ were also increased markedly in the DAF KO mice compared to the infected WT mice. More interestingly, increased viral genome copies (DNA) in the splenocytes of DAF KO mice was accompanied with mRNA transcripts in the DAF KO mice, an indication of active viral replication. These data suggest an intriguing effect of reduced DAF expression on host responses following in vivo MCMV infection.

Indexed as

AnimalsCD55 AntigensCD8-Positive T-LymphocytesDNA, ViralGene Expression Regulation, ViralHerpesviridae InfectionsHost-Pathogen InteractionsInterferon-gammaLung DiseasesMaleMiceMice, Inbred C57BLMice, KnockoutMuromegalovirusSpleenTumor Necrosis Factor-alphaCD55 AntigensDNA, ViralInterferon-gammaTumor Necrosis Factor-alpha

Identifiers

PMID21166665
PMCPMC3043310
OpenAlexW1511217667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.